label cells, followed by stimulation and subsequent quantification of radiolabelled inositol phosphates (e.g. Berridge et al., 1982 Berridge et al., , 1983 . We have recently become aware of two instances in which considerable loss of radiolabelled inositol phosphates can occur during extraction and analysis, and have found a simple remedy which we suggest could be used routinely to circumvent any future problems.
When extracting inositol phosphates from concanavalin A-treated murine thymocytes labelled with myo-['H]inositol (Moore et al., 1984) (Irvine & Moor, 1986) this loss is undesirable.
Another extraction method which under some circumstances could lead to loss of radiolabelled inositol phosphates was that of Sharpes & McCarl (1982) using Freon and tri-n-octylamine. When [3H]Ins(1,4,5)P3 (Amersham) was extracted from water using this method, < 10% remained in the aqueous upper phase. Maleic acid in the original InsP3 solution (i.e. having the InsP3 either in a Tris/maleate buffer rather than a Tris/HCl buffer, or in the presence of 75 mm-maleate, pH 7) prevented this loss, which we ascribe to the trapping of InsP3 as the octylamine salt, and its displacement by the maleate anion (Wreggett & Irvine, 1987) .
We believe both these losses during extraction are caused by the well-known phenomenon of trace amounts of compounds being bound to non-specific sites, this problem typically being alleviated by increasing the mass of the compound concerned. Thus, in this particular case, the problems may only be confined to very small amounts of tissue, and only to particular pieces of apparatus (type of filter etc.); for example, we know (C. P. Downes & P. T. Hawkins, personal communication) that no loss of any inositol phosphates occurs during extraction with trichloroacetic acid of carbacholstimulated parotid slices (Hawkins et al., 1986) ) was added to thymocytes or to the buffer described by Zilberman et al. (1987) in which they were bathed, and then extracted either with chloroform/methanol (Zieberman et al., 1987) or by trichloroacetic acid followed by ether washes (Batty et al., 1985) . Recovery was assessed by comparison with a freeze-dried sample of InsP4. All samples were analysed by h.p.l.c. (Batty et al., 1985) were routinely adopted, such potential artefacts would not occur. Table 1 shows that inclusion of a phytic acid hydrolysate containing InsP1_6 (total 25 jug of phosphorus) completely overcomes the extraction loss of InsP4 from thymocytes described above. We prepared this hydrolysate as in Desjobert & Petek (1956) , i.e. 1 g of phytate (Sigma) was dissolved in 1O ml of a pH 4.0 acetate/acetic acid (0.1 M) buffer, stoppered and incubated in a boiling-water bath for 8 h. It was then passed down a Amberlite IR-120 column (BDH Chemicals) in the H' form, dried, redissolved in water and its phosphorus content determined (Rouser et al., 1970) . This gave sufficient phytate hydrolysate to last the lifetime of an average scientist (if added to all samples in the dose given above). If used routinely, phytate hydrolysate should prevent any future problems with losses of radiolabelled inositol phosphates. The phytate hydrolysate also increases the reproducibility of ionexchange columns (Wreggett & Irvine, 1987) for the same reason (i.e. increasing the mass to above trace quantities) which is another reason to advocate its routine use.
The only potential disadvantage would be if mass measurements of inositol phosphates (e.g. Rittenhouse & Sasson, 1985) are required, or if purification of inositol phosphates is desired. Here, however, the masses are greater anyway, and so losses are less likely. If measurement of myo-inositol after dephosphorylation remains a method of choice for mass detection and analysis of inositol phosphates (Rittenhouse & Sasson, 1985) , then a mixture of inositol phosphates prepared by chemical phosphorylation of an inositol other than myoinositol would be a useful alternative. As long as radiolabelling is the predominant method used for inositol phosphate analysis, we recommend routine addition of a phytate hydrolysate.
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